炎症性肠病患者-话题@MedSci

#炎症性肠病患者#

199篇内容 | 3999人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1599995, encodeId=9e561599995d3, content=<a href='/topic/show?id=508e6e03203' target=_blank style='color:#2F92EE;'>#炎症性肠病患者#</a>, objectTitle=DDS ：非活动性炎症性肠病患者常常出现睡眠障碍, objectType=article, longId=153955, objectId=a4fb15395523, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a4fb15395523, replyNumber=0, likeNumber=68, createdTime=2018-11-21, rootId=0, userName=huangshifeng, userId=a9fa18776644, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a4fb15395523, moduleTitle=DDS ：非活动性炎症性肠病患者常常出现睡眠障碍, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a4fb15395523)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1599994, encodeId=d054159999440, content=<a href='/topic/show?id=508e6e03203' target=_blank style='color:#2F92EE;'>#炎症性肠病患者#</a>, objectTitle=JCC：抗肿瘤坏死因子α在治疗炎症性肠病患者并不增加淋巴瘤发生的风险, objectType=article, longId=150311, objectId=3c4215031151, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3c4215031151, replyNumber=0, likeNumber=51, createdTime=2018-10-04, rootId=0, userName=huangshifeng, userId=a9fa18776644, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3c4215031151, moduleTitle=JCC：抗肿瘤坏死因子α在治疗炎症性肠病患者并不增加淋巴瘤发生的风险, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=3c4215031151)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1599993, encodeId=4db915999931b, content=<a href='/topic/show?id=508e6e03203' target=_blank style='color:#2F92EE;'>#炎症性肠病患者#</a>, objectTitle=BMC Gastroenterology：维多珠单抗可用于治疗抗TNF-α治疗失败的炎症性肠病患者, objectType=article, longId=148987, objectId=884214898e10, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=884214898e10, replyNumber=0, likeNumber=63, createdTime=2018-09-18, rootId=0, userName=huangshifeng, userId=a9fa18776644, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=884214898e10, moduleTitle=BMC Gastroenterology：维多珠单抗可用于治疗抗TNF-α治疗失败的炎症性肠病患者, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=884214898e10)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1599992, encodeId=65ee15999920b, content=<a href='/topic/show?id=508e6e03203' target=_blank style='color:#2F92EE;'>#炎症性肠病患者#</a>, objectTitle=J Gastroenterology：NUDT15基因139变异是预测日本炎症性肠病患者中硫嘌呤诱导的严重不良事件的更佳药物遗传学标记物, objectType=article, longId=148482, objectId=7811148482b6, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=7811148482b6, replyNumber=0, likeNumber=37, createdTime=2018-09-10, rootId=0, userName=huangshifeng, userId=a9fa18776644, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=7811148482b6, moduleTitle=J Gastroenterology：NUDT15基因139变异是预测日本炎症性肠病患者中硫嘌呤诱导的严重不良事件的更佳药物遗传学标记物, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=7811148482b6)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1599991, encodeId=5de5159999112, content=<a href='/topic/show?id=508e6e03203' target=_blank style='color:#2F92EE;'>#炎症性肠病患者#</a>, objectTitle=2018 ESPGHAN立场声明：生物仿制药在儿童炎症性肠病患者中的应用（更新版）, objectType=article, longId=148315, objectId=4743148315b5, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=4743148315b5, replyNumber=0, likeNumber=35, createdTime=2018-09-07, rootId=0, userName=huangshifeng, userId=a9fa18776644, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=4743148315b5, moduleTitle=2018 ESPGHAN立场声明：生物仿制药在儿童炎症性肠病患者中的应用（更新版）, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=4743148315b5)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1599990, encodeId=984715999908b, content=<a href='/topic/show?id=508e6e03203' target=_blank style='color:#2F92EE;'>#炎症性肠病患者#</a>, objectTitle=JCC：炎症性肠病患者使用维多主单抗与呼吸道感染的关系, objectType=article, longId=147610, objectId=828614e61071, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=828614e61071, replyNumber=0, likeNumber=63, createdTime=2018-08-30, rootId=0, userName=huangshifeng, userId=a9fa18776644, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=828614e61071, moduleTitle=JCC：炎症性肠病患者使用维多主单抗与呼吸道感染的关系, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=828614e61071)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1599989, encodeId=d6231599989a4, content=<a href='/topic/show?id=508e6e03203' target=_blank style='color:#2F92EE;'>#炎症性肠病患者#</a>, objectTitle=Inflamm Bowel Dis：缓解期炎症性肠病患者的腹痛、腹泻症状可能与肠道微生物无关, objectType=article, longId=147074, objectId=bad814e07480, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=bad814e07480, replyNumber=0, likeNumber=33, createdTime=2018-08-22, rootId=0, userName=huangshifeng, userId=a9fa18776644, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=bad814e07480, moduleTitle=Inflamm Bowel Dis：缓解期炎症性肠病患者的腹痛、腹泻症状可能与肠道微生物无关, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=bad814e07480)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1599988, encodeId=4eba1599988ba, content=<a href='/topic/show?id=508e6e03203' target=_blank style='color:#2F92EE;'>#炎症性肠病患者#</a>, objectTitle=J Periodontol:炎症性肠病患者活化基质金属蛋白酶-8和牙周细菌水平, objectType=article, longId=144939, objectId=725f1449391b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=725f1449391b, replyNumber=0, likeNumber=58, createdTime=2018-07-23, rootId=0, userName=huangshifeng, userId=a9fa18776644, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=725f1449391b, moduleTitle=J Periodontol:炎症性肠病患者活化基质金属蛋白酶-8和牙周细菌水平, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=725f1449391b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1599987, encodeId=e96c159998e15, content=<a href='/topic/show?id=508e6e03203' target=_blank style='color:#2F92EE;'>#炎症性肠病患者#</a>, objectTitle=J Clin Gastro：粪便基质金属蛋白酶-9和脂质运载蛋白-2可以作为检测炎症性肠病患者内镜活动的生物标志物, objectType=article, longId=143003, objectId=67001430033f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=67001430033f, replyNumber=0, likeNumber=32, createdTime=2018-07-12, rootId=0, userName=huangshifeng, userId=a9fa18776644, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=67001430033f, moduleTitle=J Clin Gastro：粪便基质金属蛋白酶-9和脂质运载蛋白-2可以作为检测炎症性肠病患者内镜活动的生物标志物, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=67001430033f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1599986, encodeId=0a6d15999867d, content=<a href='/topic/show?id=508e6e03203' target=_blank style='color:#2F92EE;'>#炎症性肠病患者#</a>, objectTitle=GUT：炎症性肠病患者接受抗肿瘤坏死因子α治疗前疗效预测方法研究, objectType=article, longId=141669, objectId=852a141669f5, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=852a141669f5, replyNumber=0, likeNumber=86, createdTime=2018-06-28, rootId=0, userName=huangshifeng, userId=a9fa18776644, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=852a141669f5, moduleTitle=GUT：炎症性肠病患者接受抗肿瘤坏死因子α治疗前疗效预测方法研究, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=852a141669f5)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1599985, encodeId=f3031599985eb, content=<a href='/topic/show?id=508e6e03203' target=_blank style='color:#2F92EE;'>#炎症性肠病患者#</a>, objectTitle=Dig Dis & Sci：炎症性肠病患者使用抗肿瘤坏死因子会增加银屑病相关的发生率, objectType=article, longId=141552, objectId=8c1014155214, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=8c1014155214, replyNumber=0, likeNumber=53, createdTime=2018-06-26, rootId=0, userName=huangshifeng, userId=a9fa18776644, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=8c1014155214, moduleTitle=Dig Dis & Sci：炎症性肠病患者使用抗肿瘤坏死因子会增加银屑病相关的发生率, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=8c1014155214)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1599984, encodeId=557f15999842b, content=<a href='/topic/show?id=508e6e03203' target=_blank style='color:#2F92EE;'>#炎症性肠病患者#</a>, objectTitle=Dig Dis & Sci：小肠细菌过度生长与炎症性肠病患者的症状严重程度相关, objectType=article, longId=141551, objectId=e82814155161, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e82814155161, replyNumber=0, likeNumber=63, createdTime=2018-06-26, rootId=0, userName=huangshifeng, userId=a9fa18776644, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e82814155161, moduleTitle=Dig Dis & Sci：小肠细菌过度生长与炎症性肠病患者的症状严重程度相关, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=e82814155161)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1599983, encodeId=d78f1599983d8, content=<a href='/topic/show?id=508e6e03203' target=_blank style='color:#2F92EE;'>#炎症性肠病患者#</a>, objectTitle=Gastroenterology：病例学习，炎症性肠病患者中的肝脏肿块, objectType=article, longId=140979, objectId=662f1409e9d2, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=662f1409e9d2, replyNumber=0, likeNumber=55, createdTime=2018-06-19, rootId=0, userName=huangshifeng, userId=a9fa18776644, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=662f1409e9d2, moduleTitle=Gastroenterology：病例学习，炎症性肠病患者中的肝脏肿块, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=662f1409e9d2)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1599982, encodeId=61bb15999822e, content=<a href='/topic/show?id=508e6e03203' target=_blank style='color:#2F92EE;'>#炎症性肠病患者#</a>, objectTitle=JCC：孕妇炎症性肠病患者的维生素D不足的风险会增加：横断面研究, objectType=article, longId=139808, objectId=47d813980822, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=47d813980822, replyNumber=0, likeNumber=65, createdTime=2018-06-04, rootId=0, userName=huangshifeng, userId=a9fa18776644, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=47d813980822, moduleTitle=JCC：孕妇炎症性肠病患者的维生素D不足的风险会增加：横断面研究, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=47d813980822)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1599981, encodeId=84be159998153, content=<a href='/topic/show?id=508e6e03203' target=_blank style='color:#2F92EE;'>#炎症性肠病患者#</a>, objectTitle=Clin Gastroenterlogy and Hepatology： Vedolizumab浓度，抗药物抗体和α4β7基因与炎症性肠病患者反应的关系, objectType=article, longId=139401, objectId=508513940142, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=508513940142, replyNumber=0, likeNumber=59, createdTime=2018-05-31, rootId=0, userName=huangshifeng, userId=a9fa18776644, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=508513940142, moduleTitle=Clin Gastroenterlogy and Hepatology： Vedolizumab浓度，抗药物抗体和α4β7基因与炎症性肠病患者反应的关系, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=508513940142)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1599980, encodeId=ed901599980b1, content=<a href='/topic/show?id=508e6e03203' target=_blank style='color:#2F92EE;'>#炎症性肠病患者#</a>, objectTitle=GUT：40年随访确证炎症性肠病患者帕金森风险增加, objectType=article, longId=138821, objectId=9b6f13882140, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=9b6f13882140, replyNumber=0, likeNumber=76, createdTime=2018-05-24, rootId=0, userName=huangshifeng, userId=a9fa18776644, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9b6f13882140, moduleTitle=GUT：40年随访确证炎症性肠病患者帕金森风险增加, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=9b6f13882140)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1599979, encodeId=7da715999e932, content=<a href='/topic/show?id=508e6e03203' target=_blank style='color:#2F92EE;'>#炎症性肠病患者#</a>, objectTitle=JAMA Neurol：炎症性肠病患者接受抗TNF治疗可大幅降低后续帕金森病风险, objectType=article, longId=136341, objectId=2bd3136341a8, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=2bd3136341a8, replyNumber=0, likeNumber=75, createdTime=2018-04-26, rootId=0, userName=huangshifeng, userId=a9fa18776644, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=2bd3136341a8, moduleTitle=JAMA Neurol：炎症性肠病患者接受抗TNF治疗可大幅降低后续帕金森病风险, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=2bd3136341a8)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1599978, encodeId=8a1515999e875, content=<a href='/topic/show?id=508e6e03203' target=_blank style='color:#2F92EE;'>#炎症性肠病患者#</a>, objectTitle=GUT：炎症性肠病患者抗TNF治疗无应答预测方法研究, objectType=article, longId=134752, objectId=ae29134e52f0, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ae29134e52f0, replyNumber=0, likeNumber=60, createdTime=2018-04-12, rootId=0, userName=huangshifeng, userId=a9fa18776644, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ae29134e52f0, moduleTitle=GUT：炎症性肠病患者抗TNF治疗无应答预测方法研究, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ae29134e52f0)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1599977, encodeId=296315999e7de, content=<a href='/topic/show?id=508e6e03203' target=_blank style='color:#2F92EE;'>#炎症性肠病患者#</a>, objectTitle=2018 ESPGHAN意见书：儿童炎症性肠病患者的营养管理, objectType=article, longId=134034, objectId=677613403438, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=677613403438, replyNumber=0, likeNumber=42, createdTime=2018-04-03, rootId=0, userName=huangshifeng, userId=a9fa18776644, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=677613403438, moduleTitle=2018 ESPGHAN意见书：儿童炎症性肠病患者的营养管理, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=677613403438)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1599976, encodeId=43a915999e682, content=<a href='/topic/show?id=508e6e03203' target=_blank style='color:#2F92EE;'>#炎症性肠病患者#</a>, objectTitle=JCC：炎症性肠病患者的癌症风险与年龄和近期使用免疫调节剂有关，而生物制剂和氨基水杨酸盐是保护性因素。, objectType=article, longId=132894, objectId=8b0e1328946b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=8b0e1328946b, replyNumber=0, likeNumber=83, createdTime=2018-03-21, rootId=0, userName=huangshifeng, userId=a9fa18776644, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=8b0e1328946b, moduleTitle=JCC：炎症性肠病患者的癌症风险与年龄和近期使用免疫调节剂有关，而生物制剂和氨基水杨酸盐是保护性因素。, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=8b0e1328946b)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

炎症性肠病患者

2020-05-29

huangshifeng (审核中...)

前往app查看评论内容

#炎症性肠病患者#

DDS ：非活动性炎症性肠病患者常常出现睡眠障碍

2018-11-21

huangshifeng (审核中...)

前往app查看评论内容

#炎症性肠病患者#

JCC：抗肿瘤坏死因子α在治疗炎症性肠病患者并不增加淋巴瘤发生的风险

2018-10-04

huangshifeng (审核中...)

前往app查看评论内容

#炎症性肠病患者#

BMC Gastroenterology：维多珠单抗可用于治疗抗TNF-α治疗失败的炎症性肠病患者

2018-09-18

huangshifeng (审核中...)

前往app查看评论内容

#炎症性肠病患者#

J Gastroenterology：NUDT15基因139变异是预测日本炎症性肠病患者中硫嘌呤诱导的严重不良事件的更佳药物遗传学标记物

2018-09-10

huangshifeng (审核中...)

前往app查看评论内容

#炎症性肠病患者#

2018 ESPGHAN立场声明：生物仿制药在儿童炎症性肠病患者中的应用（更新版）

2018-09-07

huangshifeng (审核中...)

前往app查看评论内容

#炎症性肠病患者#

JCC：炎症性肠病患者使用维多主单抗与呼吸道感染的关系

2018-08-30

huangshifeng (审核中...)

前往app查看评论内容

#炎症性肠病患者#

Inflamm Bowel Dis：缓解期炎症性肠病患者的腹痛、腹泻症状可能与肠道微生物无关

2018-08-22

huangshifeng (审核中...)

前往app查看评论内容

#炎症性肠病患者#

J Periodontol:炎症性肠病患者活化基质金属蛋白酶-8和牙周细菌水平

2018-07-23

huangshifeng (审核中...)

前往app查看评论内容

#炎症性肠病患者#

J Clin Gastro：粪便基质金属蛋白酶-9和脂质运载蛋白-2可以作为检测炎症性肠病患者内镜活动的生物标志物

2018-07-12

huangshifeng (审核中...)

前往app查看评论内容

#炎症性肠病患者#

GUT：炎症性肠病患者接受抗肿瘤坏死因子α治疗前疗效预测方法研究

2018-06-28

huangshifeng (审核中...)

前往app查看评论内容

#炎症性肠病患者#

Dig Dis & Sci：炎症性肠病患者使用抗肿瘤坏死因子会增加银屑病相关的发生率

2018-06-26

huangshifeng (审核中...)

前往app查看评论内容

#炎症性肠病患者#

Dig Dis & Sci：小肠细菌过度生长与炎症性肠病患者的症状严重程度相关

2018-06-26

huangshifeng (审核中...)

前往app查看评论内容

#炎症性肠病患者#

Gastroenterology：病例学习，炎症性肠病患者中的肝脏肿块

2018-06-19

huangshifeng (审核中...)

前往app查看评论内容

#炎症性肠病患者#

JCC：孕妇炎症性肠病患者的维生素D不足的风险会增加：横断面研究

2018-06-04

huangshifeng (审核中...)

前往app查看评论内容

#炎症性肠病患者#

Clin Gastroenterlogy and Hepatology： Vedolizumab浓度，抗药物抗体和α4β7基因与炎症性肠病患者反应的关系

2018-05-31

huangshifeng (审核中...)

前往app查看评论内容

#炎症性肠病患者#

GUT：40年随访确证炎症性肠病患者帕金森风险增加

2018-05-24

huangshifeng (审核中...)

前往app查看评论内容

#炎症性肠病患者#

JAMA Neurol：炎症性肠病患者接受抗TNF治疗可大幅降低后续帕金森病风险

2018-04-26

huangshifeng (审核中...)

前往app查看评论内容

#炎症性肠病患者#

GUT：炎症性肠病患者抗TNF治疗无应答预测方法研究

2018-04-12

huangshifeng (审核中...)

前往app查看评论内容

#炎症性肠病患者#

2018 ESPGHAN意见书：儿童炎症性肠病患者的营养管理

2018-04-03

huangshifeng (审核中...)

前往app查看评论内容

#炎症性肠病患者#

JCC：炎症性肠病患者的癌症风险与年龄和近期使用免疫调节剂有关，而生物制剂和氨基水杨酸盐是保护性因素。

2018-03-21

科室
- - 订阅+
  - 更多科室
工具
服务